Acute myeloid leukaemia with associated eosinophilia: Justification for FIP1L1-PDGFRA screening in cases lacking the CBFB-MYH11 fusion gene: Correspondence

British Journal of Haematology

Volumn 146, Issue 2, 2009, Pages 225-227

  Sorour, Youssef ^a   Dalley, Christopher D ^a   Snowden, John A ^a   Cross, Nicholas C P ^b   Reilly, John T ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

AML; Eosinophilia; FIP1L1 PDGFRA; Imatinib

Indexed keywords

CYTARABINE; DASATINIB; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMATINIB;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; CASE REPORT; CLINICAL FEATURE; EOSINOPHILIA; EOSINOPHILIC LEUKEMIA; FUSION GENE; GENE MUTATION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; EOSINOPHILIA; GENETIC TESTING; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; ONCOGENE PROTEINS, FUSION; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA;

EID: 67650001498     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07746.x     Document Type: Letter

References (10)

1. von Bubnoff, N., Sandherr, M., Schlimok, G., Andreesen, R., Peschel, C. Duyster, J. (2005) Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia. Leukemia, 19, 286 287. (Pubitemid 40220595)
2. Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, R.D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J.D., Cross, N.C., Tefferi, A., Malone, J., Alam, R., Schrier, S.L., Schmid, J., Rose, M., Vandenberghe, P., Verhoef, G., Boogaerts, M., Wlodarska, I., Kantarjian, H., Marynen, P., Coutre, S.E., Stone, R. Gilliland, D.G. (2003a) A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. New England Journal of Medicine, 348, 1201 1214. (Pubitemid 36359296)
3. Cools, J., Stover, E.H., Boulton, C.L., Gotlib, J., Legare, R.D., Amaral, S.M., Curley, D.P., Duclos, N., Rowan, R., Kutok, J.L., Lee, B.H., Williams, I.R., Coutre, S.E., Stone, R.M., DeAngelo, D.J., Marynen, P., Manley, P.W., Meyer, T., Fabbro, D., Neuberg, D., Weisberg, E., Griffin, J.D. Gilliland, D.G. (2003b) PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease. Cancer Cell, 3, 459 469. (Pubitemid 38340293)
4. Cools, J., Quentmeier, H., Huntly, B.J., Marynen, P., Griffin, J.D., Drexler, H.G. Gilliland, G.D. (2004) The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood, 103, 2802 2805. (Pubitemid 38393041)
5. Dewaele, B., Wasag, B., Cools, J., Sciot, R., Prenen, H., Vandenberghe, P., Wozniak, A., Schöffski, P., Marynen, P. Debiec-Rychter, M. (2008) Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRA D842V mutation. Clinical Cancer Research, 14, 5749 5758.
6. Gleixner, K.V., Mayerhofer, M., Sonneck, K., Gruze, A., Samorapoompichit, P., Baumgartner, C., Lee, F.Y., Aichberger, K.J., Manley, P.W., Fabbro, D., Pickl, W.F., Sillaber, C. Valent, P. (2007) Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT. Haematologica, 92, 1451 1459. (Pubitemid 350144119)
7. Griffin, J.H., Leung, J., Bruner, R.J., Caligiuri, M.A. Briesewitz, R. (2003) Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 100, 7830 7835. (Pubitemid 36760055)
8. Metzgeroth, G., Walz, C., Score, J., Siebert, R., Schnittger, S., Haferlach, C., Popp, H., Haferlach, T., Erben, P., Mix, J., Müller, M.C., Beneke, H., Müller, L., Del Valle, F., Aulitzky, W.E., Wittkowsky, G., Schmitz, N., Schulte, C., Müller-Hermelink, K., Hodges, E., Whittaker, S.J., Diecker, F., Döhner, H., Schuld, P., Hehlmann, R., Hochhaus, A., Cross, N.C.P. Reiter, A. (2007) Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia, 21, 1183 1188. (Pubitemid 46831806)
9. Ohnishi, H., Kandabashi, K., Maeda, Y., Kawamura, M. Watanabe, T. (2006) Chronic eosinophilic leukaemia with FIP1L1-PDGFRA fusion and T6741 mutation that evolved from Langerhans cell histiocytosis with eosinophilia after chemotherapy. British Journal of Haematology, 134, 547 549. (Pubitemid 44141723)
10. Score, J., Walz, C., Jovanovic, J.V., Jones, A.V., Waghorn, K., Hidalgo-Curtis, C., Lin, F., Grimwade, D., Grand, F., Reiter, A. Cross, N.C. (2009) Detection and molecular monitoring of FIP1L1-PDGFRA-positive disease by analysis of patient-specific genomic DNA fusion junctions. Leukemia, 23, 332 339.